NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

成藥的全球市場:2020-2026年

Over-the-Counter Drugs Market - By Product : Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

出版商 Zion Market Research 商品編碼 956612
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
成藥的全球市場:2020-2026年 Over-the-Counter Drugs Market - By Product : Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026
出版日期: 2020年08月05日內容資訊: 英文 110 Pages
簡介

本報告提供全球成藥的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的轉變·預測,產品·地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊。

第1章 序文

第2章 摘要整理

第3章 產業分析

  • 市場動態
  • 成長推進因素
  • 阻礙成長要素
  • 市場機會
  • 波特的五力分析
  • 市場魅力

第4章 競爭情形

  • 企業佔有率分析
  • 策略性展開
  • 價格趨勢分析

第5章 市場分析·預測:各產品

  • 止咳藥·流感藥
  • 止痛藥
  • 感冒藥
  • 減重產品
  • 維生素·礦物質補充品
  • 腸胃藥
  • 眼科藥
  • 皮膚藥
  • 其他

第6章 市場分析·預測:地區·各主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 企業簡介

  • GlaxoSmithKline (GSK)
  • Sun Pharmaceutical Industries Ltd.
  • Bayer HealthCare
  • Johnson & Johnson
  • Pfizer
  • Sanofi
  • Alkem Laboratories Limited
  • Glenmark Pharmaceuticals Ltd.
  • Cipla, Inc.
  • Takeda
  • Teva Pharmaceutical Industries Ltd.
  • Reckitt Benckiser Group Plc
  • Innovus Pharmaceutical Inc.
  • Piramal
  • Dr. Reddy's Laboratories
目錄

Title:
Over-the-Counter Drugs Market - By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026.

The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counter drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the over-the-counter drugs market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the over-the-counter drugs market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment is benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the over-the-counter drugs market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the over-the-counter drugs market on global and regional basis.

Global Over-the-Counter Drugs Market: By Product

  • Cough & Flu Products
  • Analgesics
  • Cold
  • Weight Loss Products
  • Mineral and Vitamin Supplements
  • Gastrointestinal Products
  • Ophthalmic Products
  • Skin Products
  • Others

Global Over-the-Counter Drugs Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Contents

Chapter 1. Preface

  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodulogy
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodulogy

Chapter 2. Executive Summary

  • 2.1. N95 Mask Market, 2016 – 2026 (USD Million)
  • 2.2. N95 Mask Market: Snapshot

Chapter 3. N95 Mask Market – Industry Analysis

  • 3.1. N95 Mask Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Increasing trend of self-medication
    • 3.2.2. Growing patent expirations
  • 3.3. Restraints
    • 3.3.1. Concerns regarding improper diagnosis
    • 3.3.2. Issues related to substance abuse
  • 3.4. Opportunities
    • 3.4.1. Product innovation
  • 3.5. Porter’s Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis by Product
    • 3.6.2. Market attractiveness analysis by Region

Chapter 4. N95 Mask Market– Competitive Landscape

  • 4.1. Company market share analysis
    • 4.1.1. Global N95 Mask Market: company market share, 2019
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis

Chapter 5. Global N95 Mask Market –Product Analysis

  • 5.1. Global N95 Mask Market overview: by Product
    • 5.1.1. Global N95 Mask Market share, by Product, 2019 and 2026
  • 5.2. Cough & Flu Products
    • 5.2.1. Global N95 Mask Market by Cough & Flu Products, 2016 – 2026 (USD Million)
  • 5.3. Analgesics
    • 5.3.1. Global N95 Mask Market by Analgesics, 2016 – 2026 (USD Million)
  • 5.4. Culd
    • 5.4.1. Global N95 Mask Market by Culd, 2016 – 2026 (USD Million)
  • 5.5. Weight Loss Products
    • 5.5.1. Global N95 Mask Market by Weight Loss Products, 2016 – 2026 (USD Million)
  • 5.6. Mineral and Vitamin Supplements
    • 5.6.1. Global N95 Mask Market by Mineral and Vitamin Supplements, 2016 – 2026 (USD Million)
  • 5.7. Gastrointestinal Products
    • 5.7.1. Global N95 Mask Market by Gastrointestinal Products, 2016 – 2026 (USD Million)
  • 5.8. Ophthalmic Products
    • 5.8.1. Global N95 Mask Market by Ophthalmic Products, 2016 – 2026 (USD Million)
  • 5.9. Skin Products
    • 5.9.1. Global N95 Mask Market by Skin Products, 2016 – 2026 (USD Million)
  • 5.10. Others
    • 5.10.1. Global N95 Mask Market by Others, 2016 – 2026 (USD Million)

Chapter 6. Global N95 Mask Market - Regional Analysis

  • 6.1. Global N95 Mask Market overview: by Region
    • 6.1.1. Global N95 Mask Market share, by Region, 2019 and 2026
  • 6.2. North America
    • 6.2.1. North America N95 Mask Market, 2016 – 2026 (USD Million)
    • 6.2.2. North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.2.3. U.S.
      • 6.2.3.1. U.S. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.2.4. Rest of North America
      • 6.2.4.1. Rest of North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe N95 Mask Market, 2016 – 2026 (USD Million)
    • 6.3.2. Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. U.K. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.3.5. Germany
      • 6.3.5.1. Germany N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.3.6. Rest of Europe
      • 6.3.6.1. Rest of Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific N95 Mask Market, 2016 – 2026 (USD Million)
    • 6.4.2. Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Japan N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.4.5. India
      • 6.4.5.1. India N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.4.6. Rest of Asia Pacific
      • 6.4.6.1. Rest of Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America N95 Mask Market, 2016 – 2026 (USD Million)
    • 6.5.2. Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.5.3. Brazil
      • 6.5.3.1. Brazil N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.5.4. Rest of Latin America
      • 6.5.4.1. Rest of Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
  • 6.6. The Middle East and Africa
    • 6.6.1. The Middle East and Africa N95 Mask Market, 2016 – 2026 (USD Million)
    • 6.6.2. The Middle East and Africa N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)

Chapter 7. Company Profiles

  • 7.1. GlaxoSmithKline (GSK)
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Usage Portfulio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Sun Pharmaceutical Industries Ltd.
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Usage Portfulio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. Bayer HealthCare
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Usage Portfulio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. Johnson & Johnson
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Usage Portfulio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Developments
  • 7.5. Pfizer
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Usage Portfulio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Development
  • 7.6. Sanofi
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Usage Portfulio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Development
  • 7.7. Alkem Laboratories Limited
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Usage Portfulio
    • 7.7.4. Business Strategy
    • 7.7.5. Recent Development
  • 7.8. Glenmark Pharmaceuticals Ltd.
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Usage Portfulio
    • 7.8.4. Business Strategy
    • 7.8.5. Recent Development
  • 7.9. Cipla, Inc.
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Usage Portfulio
    • 7.9.4. Business Strategy
    • 7.9.5. Recent Development
  • 7.10. Takeda
    • 7.10.1. Overview
    • 7.10.2. Financials
    • 7.10.3. Usage Portfulio
    • 7.10.4. Business Strategy
    • 7.10.5. Recent Development
  • 7.11. Teva Pharmaceutical Industries Ltd.
    • 7.11.1. Overview
    • 7.11.2. Financials
    • 7.11.3. Usage Portfulio
    • 7.11.4. Business Strategy
    • 7.11.5. Recent Development
  • 7.12. Reckitt Benckiser Group Plc
    • 7.12.1. Overview
    • 7.12.2. Financials
    • 7.12.3. Usage Portfulio
    • 7.12.4. Business Strategy
    • 7.12.5. Recent Development
  • 7.13. Innovus Pharmaceutical Inc.
    • 7.13.1. Overview
    • 7.13.2. Financials
    • 7.13.3. Usage Portfulio
    • 7.13.4. Business Strategy
    • 7.13.5. Recent Development
  • 7.14. Piramal
    • 7.14.1. Overview
    • 7.14.2. Financials
    • 7.14.3. Usage Portfulio
    • 7.14.4. Business Strategy
    • 7.14.5. Recent Development
  • 7.15. Dr. Reddy's Laboratories
    • 7.15.1. Overview
    • 7.15.2. Financials
    • 7.15.3. Usage Portfulio
    • 7.15.4. Business Strategy
    • 7.15.5. Recent Development